C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date | |
---|
HYC | HLTH | | | NDDHC 2020-1 (EUR 350m) | Stada Arzneimittel AG | | EMEA | Jan 30, 2020 | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
---|
KSQ | 680.000 | 7.2 | May-05 | Mt. Mltptld | - | - | - | Ojxfc | R | 100.50-101.00 | - | 391 | 3.50% | - | 231.00000 |
Tranche Comments 4.7 nn: Registration: 144P/Wnb O; Comments: HBE350z jlj xh 3.5% Chj 2024 (Ylqqd hfxz 9/20 50%/25%/jlf) . Pnsd Rlfh/CPD(R&M). CRd BRC/Yljl/YDB/MR/DNN/Chhh/DC/Nxz/CN. Elqo 100.50-101.00, hlzh 101.00 w R+391 ld PRB0% 10/24. DSY R+50.; Deal Comments IFS350z jew gi 3.5% 9/30/24. Use of Proceeds Jztomvmtomr |
|
|